Genor Biopharma Holdings Limited (stock code: 06998) released its Monthly Return for the equity issuer and Hong Kong depositary receipts for October 2025. According to the announcement, the company’s authorized share capital remained at 1,000,000,000 ordinary shares, amounting to USD 20,000. There was no increase or decrease in the total number of issued shares, which ended the month at 528,291,792.

The announcement also detailed multiple share option plans and restricted share unit grants under the company’s share schemes. However, no new shares were issued and no treasury shares were transferred during the reporting period. Warrants and convertibles were not applicable in this return, and the company confirmed that all relevant listing rules and regulatory requirements were met.